Your browser doesn't support javascript.
loading
Potential of chitosan/alginate nanoparticles as a non-viral vector for gene delivery: Formulation and optimization using D-optimal design.
Zohri, Maryam; Arefian, Ehsan; Akbari Javar, Hamid; Gazori, Taraneh; Aghaee-Bakhtiari, Seyed Hamid; Taheri, Mojtaba; Fatahi, Yousef; Azadi, Amir; Khoshayand, Mohammad Reza; Ghahremani, Mohammad Hossein.
Afiliación
  • Zohri M; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Arefian E; Department of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran. Electronic address: Arefian@ut.ac.ir.
  • Akbari Javar H; Departments of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Gazori T; Trita Nanomedicine Research Center (TNRC), Trita Third Millennium Pharmaceuticals, 1917733831 Tehran, Iran.
  • Aghaee-Bakhtiari SH; Bioinformatics Research Group, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Taheri M; Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Fatahi Y; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Azadi A; Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Khoshayand MR; Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghahremani MH; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran. Electronic address: mhghahremani@tums.ac.ir.
Mater Sci Eng C Mater Biol Appl ; 128: 112262, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34474821
ABSTRACT
Chitosan/alginate (Chi/Alg) nanoparticles as a non-viral vector for the Smad4 encoding plasmid were optimized utilizing D-optimal design based on the nanoparticles/plasmid ratio, Chi/Alg MW, and preparation method type. Following the optimization and validation of the best formula, morphology studies and FTIR measurements were performed to evaluate the optimized Chi/Alg/S NPs. Toxicity (MTT assay) and transfection studies were performed for the best formula in comparison with Lipofectamine 2000, and Polyethyleneimine (PEI) and evaluated using Green Fluorescence Protein (GFP) assay, Flow cytometry, and RT-PCR. The model predicted a particle size of 111 nm, loading efficacy (LE) of 43%, cumulative release (CMR) of 39%, the ζ-potential of +50 mV, and PDI of 0.13. The predicted point condition was as follows NP ratio = 13, Chi/Alg MW ratio = 2.35, and preparation method type = 1. Microscopic findings revealed that the shape of nanoparticles was spherical. The Chi/Alg/S nanoparticles showed no toxicity and transfection efficacy of 29.9% was observed in comparison with Lipofectamine (35.5%) and PEI (30.9%).
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas Tipo de estudio: Prognostic_studies Idioma: En Revista: Mater Sci Eng C Mater Biol Appl Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Quitosano / Nanopartículas Tipo de estudio: Prognostic_studies Idioma: En Revista: Mater Sci Eng C Mater Biol Appl Año: 2021 Tipo del documento: Article País de afiliación: Irán
...